Evidence for genetic susceptibility towards development of posttransplant lymphoproliferative disorder in solid organ recipients

Transplantation

Volumn 84, Issue 3, 2007, Pages 387-391

  Babel, Nina ^a   Vergopoulos, Athanasios ^a   Trappe, Ralf Ulrich ^a   Oertel, Stephan ^b   Hammer, Markus H ^a   Karaivanov, Stoyan ^a   Schneider, Natalia ^a   Riess, Hanno ^a   Papp Vary, Matthias ^a   Neuhaus, Ruth ^a   Gondek, Lukasz Pawel ^c   Volk, Hans Dieter ^a   Reinke, Petra ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ROCHE INNOVATION CENTER MUNICH   (Germany)

^c TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

Cytokine; Epstein Barr virus; Posttransplant lymphoproliferative disorder; Single nucleotide polymorphism; Transplantation

Indexed keywords

CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; EPSTEIN BARR VIRUS; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAFT RECIPIENT; HUMAN; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; LYMPHOPROLIFERATIVE DISEASE; MALE; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; PATHOGENESIS; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; CASE-CONTROL STUDIES; DISEASE PROGRESSION; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547865361     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000269617.60751.c4     Document Type: Article

References (23)

1. Hanto DW. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: Implications for understanding their pathogenesis and developing rational treatment strategies. Annu Rev Med 1995; 46: 381.
2. Swinnen LJ. Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 2000; 11(Suppl 1): 45.
3. Shapiro R, Nalesnik M, McCauley J, et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 1999; 68: 1851.
4. Cox KL, Lawrence-Miyasaki LS, Garcia-Kennedy R, et al. An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK 506 after liver transplantation. Transplantation 1995; 27: 524.
5. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 1993; 56: 88.
6. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: On-line databases. Genes Immun 1999; 1: 3.
7. Lan Q, Zheng T, Rothman N, et al. Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood 2006; 107: 4101.
8. Chaouchi N, Arvanitakis L, Auffredou MT, et al. Characterization of transforming growth factor-beta 1 induced apoptosis in normal human B cells and lymphoma B cell lines. Oncogene 1995; 11: 1615.
9. Nalesnik MA, Starzl TE. Epstein-Barr virus, infectious mononucleosis, and posttransplant lymphoproliferative disorders. Transplant Sci 1994; 4: 61.
10. Helminen M, Lahdenpohja N, Hurme M. Polymorphism of the interleukin-10 gene is associated with susceptibility to Epstein-Barr virus infection. J Infect Dis 1999; 180: 496.
11. Jabs WJ, Hennig H, Kittel M, et al. Normalized Quantification by Real-Time PCR of Epstein-Barr Virus Load in Patients at Risk for Posttransplant Lymphoproliferative Disorders. J Clin Microbiol 2001; 39: 564.
12. McLaughlin K, Wajstaub S, Marotta P, et al. Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C. Liver Transpl 2000; 6: 570.
13. Smith JM, Rudser K, Gillen D, et al. Risk of lymphoma after renal transplantation varies with time: An analysis of the United States Renal Data System. Transplantation 2006; 81: 175.
14. Shahinian VB, Muirhead N, Jevnikar AM, et al. Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoproliferative disorder in adult renal allograft recipients. Transplantation 2003; 75: 851.
15. Li MO, Wan YY, Sanjabi S, et al. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006; 24: 99.
16. Massague J, Blain SW, Lo RS. TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103: 295.
17. Kee BL, Rivera RR, Murre C. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat Immunol 2001; 2: 242.
18. Tan EL, Selvaratnam G, Kananathan R, Sam CK. Quantification of Epstein-Barr virus DNA load, interleukin-6, interleukin-10, transforming growth factor-beta1 and stem cell factor in plasma of patients with nasopharyngeal carcinoma. BMC Cancer 2006; 6: 227.
19. Muti G, Klersy G, Baldanti F, et al. Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders. Br J Haematol 2003; 122: 927.
20. Turner D, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 1997; 24: 1.
21. Rosset F, Garcia E, Defrance T, et al. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A 1992; 89: 1890.
22. Purdue MP, Lan Q, Kricker A. Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: Findings from the New South Wales non-Hodgkin lymphoma study. Carcinogenesis 2007; 28: 704.
23. Lee TC, Savoldo B, Barshes NR, et al. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients. Clin Transplant 2006; 20: 389.